Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Therapy areas
Dermatology
Dermatology
Cardio-metabolism
Dermatology
Gastroenterology
Genitourinary
Haematology
Immuno-inflammation
Immuno-oncology
Infectious diseases
Musculoskeletal
Neurology
Nutritional Supplements
Ophthalmology
Orphan-paediatric
Others
Psychiatry
Respiratory
Vaccine
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dermatology
Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis
Biospace News
-
February 25, 2020
Dermatology
Incyte’s ruxolitinib cream achieves main goal in second late-stage atopic dermatitis study
Firstwordpharma News
-
February 19, 2020
Dermatology
Incyte’s ruxolitinib cream achieves main goal in second late-stage atopic dermatitis...
Firstwordpharma News
-
February 19, 2020
0
Dermatology
Incyte’s Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints
Biospace News
-
January 28, 2020
0
Dermatology
Incyte’s cream formulation of ruxolitinib hits main goal of late-stage atopic...
Firstwordpharma News
-
January 28, 2020
0
Dermatology
Concert Pharmaceuticals Successfully Completes Open Label Trial of CTP-543 in Patients...
Firstwordpharma News
-
December 19, 2019
0
Dermatology
LEO Pharma’s experimental drug tralokinumab hits main goals of three pivotal...
Firstwordpharma News
-
December 11, 2019
0
1
2
3
...
5
Page 1 of 5
- Advertisement -
LATEST NEWS
Biogen Loses $18B in Value as It Kills Aducanumab Alzheimer’s Program
Biospace News
-
March 21, 2019
0
PULS changes its name to AQILION AB
March 12, 2019
Building a safer CAR-T therapy
February 3, 2020
MUST READ
Strongbridge Biopharma plc to Present at Two Upcoming Investor Conferences
Biospace News
-
November 12, 2019
0
Selectively Targeting Cancerous T-Cells Using CAR-T Therapy
Biospace News
-
July 16, 2019
0
Adding chemotherapy to radiotherapy for bladder cancer shows benefits for patients
Firstwordpharma News
-
January 21, 2020
0
Load more
